Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

5.3%

1 terminated/withdrawn out of 19 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

16%

3 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

8 recruiting

Enrollment Performance

Analytics

Phase 2
3(37.5%)
N/A
2(25.0%)
Phase 3
2(25.0%)
Phase 4
1(12.5%)
8Total
Phase 2(3)
N/A(2)
Phase 3(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (19)

Showing 19 of 19 trials
NCT06202638Recruiting

Hypotension Prediction Index (HPI) in Lung Resections

Role: lead

NCT04705337Phase 4Terminated

Levosimendan In Ambulatory Heart Failure Patients

Role: collaborator

NCT05508035Phase 3Recruiting

The Effect of Sacubitril/valsartan Versus Ramipril on Left Ventricular Function and Remodeling in Patients with Ischemic Heart Failure with Mid-range Ejection Fraction

Role: lead

NCT06584266Recruiting

Multimodal Cardiac Imaging Registry in Patients with Atrial Fibrillation

Role: collaborator

NCT06345235Recruiting

New Biomarkers and Plasma Prothrombotic Potential in Cardiac Transthyretin Amyloidosis

Role: lead

NCT05776043Phase 3Unknown

Empagliflozin and Dapagliflozin in Patients Hospitalized for Acute Decompensated Heart Failure

Role: collaborator

NCT04703751Not ApplicableUnknown

Evaluation of the CIRCULATE Catheter for Transcoronary Administration of Pharmacologic and Cell-based Agents

Role: lead

NCT04271033Not ApplicableRecruiting

MicroNet-covered Stent System for Stroke Prevention in All Comer Carotid Revascularization

Role: lead

NCT05195658Recruiting

Acute Stroke of CArotid Artery Bifurcation Origin Treated With Use oF the MicronEt-covered CGUARD (SAFEGUARD-STROKE)

Role: lead

NCT05250349Recruiting

TRAnscranial Doppler CErebral Blood Flow and Cognitive IMPAIRment in Heart Failure

Role: lead

NCT05183373Unknown

Inflammation and Clotting Abnormalities in Aneurysmal Coronary Artery Disease

Role: lead

NCT04234854Unknown

OPTIMAl Endovascular Exclusion of Consecutive Patient High-risk Carotid Plaque Using the MicroNet Covered Stent

Role: lead

NCT04973579Recruiting

Simultaneous Cardiac Surgery and Micronet-covered Stent Carotid Revascularization in High Perioperative Stroke Risk Patients

Role: lead

NCT03423732Phase 2Unknown

Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With No-option Critical Limb Ischemia (N-O CLI)

Role: lead

NCT03418233Phase 2Completed

Randomized Clinical Trial to Evaluate the Regenerative Capacity of CardioCell in Patients With Chronic Ischaemic Heart Failure (CIHF)

Role: lead

NCT03404063Phase 2Completed

Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With Acute Myocardial Infarction (AMI)

Role: lead

NCT04547387Unknown

TCAR Cerebral Protection And MicroNET-Covered Stent To Reduce Strokes

Role: lead

NCT04434456Unknown

Carotid Artery Aneurysm Treatment Using CGuard Divert-And-Heal Strategy

Role: lead

NCT04461717Unknown

Micronet Covered Stent in in Arterial Locations Beyond the Carotid Bifurcation - FLOW-Guard Study

Role: lead

All 19 trials loaded